The FreeStyle Libre portfolio keeps members, caregivers, and healthcare providers (HCPs) connected and ready to make the best treatment decisions possible.
Each CGM in the FreeStyle Libre portfolio gives members glucose readings every minute3,4.
Members get real-time data and trends on their smartphones||¶ or readers#** and can be alerted the minute their glucose is too high or too low3,4.
The FreeStyle Libre 2 system and the FreeStyle Libre 3 system are indicated for use in women with all types of diabetes (type 1, type 2, and gestational) who are pregnant.
The FreeStyle Libre 3 system is easy*2,5 to use and features the world’s smallest, thinnest††, most discreet5 CGM sensor. Now members can know sooner, act faster, and be ready to avoid lows.
The FreeStyle Libre 2 system offers the benefits of a CGM to the widest array of members.
FreeStyle Libre 3 system
|
FreeStyle Libre 2 system
|
|
|---|---|---|
| Alarms |
Real-time glucose readings and real-time alarms§ |
Real-time glucose readings and real-time alarms‡ |
| Glucose viewing |
Stream (to app|| or reader**) |
Scan (to app¶ or reader#) |
| Sensor wear |
14-day |
14-day |
| Configuration |
Sensor with app|| or reader** |
Sensor with app¶ or reader# |
| Age range |
Ages 4 and above |
Ages 4 and above |
| Applicator |
1-piece |
2-piece |
| Sensor size |
0.83” x 0.11” |
1.18” x 0.2” |
| Bluetooth range |
33 feet |
20 feet |
Making glucose data more accessible for everyone involved allows for more informed diabetes management decisions*6.
Get an introduction to continuous glucose monitoring.
Read up on the latest, growing body of clinical evidence for the FreeStyle Libre portfolio.
See how the FreeStyle Libre portfolio represents savings‡‡5 for members and payers alike.
Get the latest industry news, updates, and announcements, plus find out all there is to know about the FreeStyle Libre portfolio of products.
Product images are for illustrative purposes only. Not actual patient data.
Medicare coverage is available for the FreeStyle Libre systems if their respective readers are used to review glucose data on some days every month. Medicare and other third party payor criteria apply.
Abbott provides this information as a courtesy; it is subject to change and interpretation. The customer is ultimately responsible for determining the appropriate codes, coverage, and payment policies for individual patients. Abbott does not guarantee third party coverage or payment for our products or reimburse customers for claims that are denied by third party payors.
The LibreLinkUp app is only compatible with certain mobile devices and operating systems. Please check www.librelinkup.com for more information about device compatibility before using the app. Use of the LibreLinkUp app requires registration with LibreView. LibreLinkUp is not intended to be used for dosing decisions. The user should follow instructions on the continuous glucose monitoring system. LibreLinkUp is not intended to replace self-monitoring practices as advised by a physician.
The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.
The FreeStyle Libre 2 system and FreeStyle Libre 3 system are indicated for patients ages 4 and older.
* Data from this study was collected with the outside US version of the FreeStyle Libre 14 day system. FreeStyle Libre 3 has the same features as FreeStyle Libre 14 day system with real-time glucose alarms. Therefore the study data is applicable to both products.
† Data from this study was collected with the outside US version of the FreeStyle Libre 14 day system. FreeStyle Libre 2 has the same features as FreeStyle Libre 14 day system with optional real-time glucose alarms. Therefore the study data is applicable to both products.
‡ Notifications will only be received when alarms are turned on and the sensor is within 20 feet of the reading device. You must enable the appropriate settings on your smartphone to receive alarms and alerts, see the FreeStyle Libre 2 User’s Manual for more information.
§ Notifications will only be received when alarms are turned on and the sensor is within 33 feet unobstructed of the reading device. You must enable the appropriate settings on your smartphone to receive alarms and alerts, see the FreeStyle Libre 3 User’s Manual for more information.
|| The FreeStyle Libre 3 app is only compatible with certain mobile devices and operating systems. Please check our website for more information about device compatibility before using the app.
¶ The FreeStyle Libre 2 app is only compatible with certain mobile devices and operating systems. Please check our website for more information about device compatibility before using the app. Use of the FreeStyle Libre 2 app requires registration with LibreView.
# The FreeStyle Libre 2 app and the FreeStyle Libre 2 reader have similar but not identical features. Fingersticks are required for treatment decisions when you see Check Blood Glucose symbol and when your glucose alarms and readings from the system do not match symptoms or expectations.
** The FreeStyle Libre 3 app and the FreeStyle Libre 3 reader have similar but not identical features. Fingersticks are required for treatment decisions when you see the Check Blood Glucose symbol and when your glucose alarms and readings from the system do not match symptoms or expectations.
†† Among patient-applied sensors.
‡‡ Based on a comparison of list prices of the FreeStyle Libre personal CGM systems versus competitors’ CGM systems, assuming annual use of one receiver (or equivalent hardware) and quantity of transmitters and/or sensors according to use life. The actual cost to patients may or may not be lower than other CGM systems, depending on the amount covered by insurance, if any.
References: 1. Campbell, F. Pediatr Diabetes (2018): https://doi.org/10.1111/pedi.12735 2. Haak, T. Diabetes Ther (2017): https://doi.org/10.1007/s13300-016-0223-6 3. FreeStyle Libre 2 User’s Manual. 4. FreeStyle Libre 3 User’s Manual. 5. Data on file, Abbott Diabetes Care. 6. Unger, J. Postgrad Med (2020): https://doi.org/10.1080/00325481.2020.1744393
ADC-76900 v1.0
Important Safety Information
FreeStyle Libre 14 day, FreeStyle Libre 2 and FreeStyle Libre 3 systems: Failure to use FreeStyle Libre systems as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If glucose reading and alarms (if enabled) do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855-632-8658 or FreeStyleLibre.us for safety info.
The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. Other trademarks are the property of their respective owners.
No use of any Abbott trademark, trade name, or trade dress in this site may be made without prior written authorization of Abbott Laboratories, except to identify the product or services of the company.
This website and the information contained herein is intended for use by residents of the United States.
ADC-85718 v2.0
Payer.freestylelibre.us/en is a product-specific website intended only for residents of the United States.
If you are a resident of another country, please contact your local Abbott affiliate to obtain the appropriate product information for your country of residence.
ADC-21099 v3.0 07/21
Stay connected